Hidoc Updates

New Cancer Therapy: The US Food and Drug Administration (FDA) has granted the review of glofitamab. It will be reviewed for relapsed or refractory large […]

New Cancer Therapy: The recent research publication in the Proceedings of the National Academy of Sciences has presented the concept of predicting breast cancer treatment […]

Global Healthcare trends: A meeting took place on 30 December between WHO and China. It focus on discussing the current situation of China due to […]

Healthcare trends 2022: “While patients with more advanced HIV are known to be at greater risk for COVID-19. It is still a question whether vaccination […]

Healthcare trends 2022: Health ministry of India has advised the citizens to take all preventive measures against COVID-19. The measures include getting vaccinated and wearing […]

Healthcare trends 2022: Even after Three years of COVID-19 outbreak in China, the country seems to be at its worst.  Millions of the citizens are […]

Clinical Drug Development Process: A Phase I/II trial of monoclonal antibody (mAb) AOC 1001 is successfully done aiming for the targeted delivery of siRNA into […]

Biologics development: The first ever use of base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy was done on a thirteen-year-old patient suffering from […]

Clinical Phases of Drug Development: Among the different clinical phases of drug development, a phase II trial of Dostarlimab was done and is presented in […]

Healthcare technology news: According to the findings published in the British Journal of Ophthalmology the retina’s network of the veins and arteries can help in […]

Latest radiotherapy news today: According to a phase I trial analysis, radiation treatment combined with immunotherapy is superior to radiotherapy alone in treating metastatic non-small […]

Pharma Global News: U.S. Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Hemophilia B. Particularly, this […]

World pharma news: RELEUKO® (filgrastim-ayow), a biosimilar to Neupogen, was officially launched by Amneal Pharmaceuticals, Inc. Amneal pharmaceuticals in collaboration with Kashiv Biosciences developed this […]

Healthcare news today features a machine-learning technology that has been developed to predict which patients are most likely to develop COVID-19. The technology has been […]

Pharma Marketing Practices: A 5-member panel formed by the government to review the marketing practices of pharmaceutical companies and examine the requirement for a legally […]

A 16-month-old toddler from Ottawa city, Canada is being celebrated in the scientific community as the first child to get in-utero treatment for a genetic disorder […]